Delivery Order SPE2DB22D2206-SPE2DB25FJW76
- Not listed
- The Defense Logistics Agency awarded a $1,650.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of August 21, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,152.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ALBUKED-25 vials. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment programs and...
- The Defense Logistics Agency awarded a delivery order valued at $4,563.00 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML pharmaceutical supplies. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive set-aside award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,509.65 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of ALBUKED-25 vials in 100ml quantities. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of August 13, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $76,278.37 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, issued under a competitive process with no set-aside designation, is performed at AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader procurement relationship with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.30 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceuticals, medical supplies, and related distribution services to support military treatment...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $158,944.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The work will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,009.28 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The delivery order represents a small-value...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJW76Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,320.60 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML pharmaceutical products on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal medical procurement. This delivery order is issued under AmerisourceBergen's comprehensive IDC with the Defense Logistics Agency valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's contract awards with DLA demonstrate its established capability to fulfill diverse medical supply requirements across multiple therapeutic domains, positioning it as a key supplier for the Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/11/25 |